|
GZF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.160730E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.136920E-03 |
| Normal-vs-Stage2 |
1.572270E-02 |
| Normal-vs-Stage3 |
3.091600E-02 |
| Normal-vs-Stage4 |
3.623200E-03 |
| Stage1-vs-Stage2 |
9.977800E-01 |
| Stage1-vs-Stage3 |
6.663400E-01 |
| Stage1-vs-Stage4 |
6.559800E-01 |
| Stage2-vs-Stage3 |
7.545400E-01 |
| Stage2-vs-Stage4 |
7.416200E-01 |
| Stage3-vs-Stage4 |
4.768000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.284560E-03 |
| Normal-vs-AfricanAmerican |
5.016100E-03 |
| Normal-vs-Asian |
3.502000E-02 |
| Caucasian-vs-AfricanAmerican |
5.837600E-01 |
| Caucasian-vs-Asian |
3.843000E-01 |
| AfricanAmerican-vs-Asian |
2.844600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.829500E-04 |
| Normal-vs-Female |
7.296700E-03 |
| Male-vs-Female |
8.784400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.221100E-04 |
| Normal-vs-Extreme_Weight |
3.012500E-04 |
| Normal-vs-Obese |
4.237500E-03 |
| Normal-vs-Extreme_Obese |
6.158000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.933600E-01 |
| Normal_Weight-vs-Obese |
2.103000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.634600E-01 |
| Extreme_Weight-vs-Obese |
1.482160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.339200E-01 |
| Obese-vs-Extreme_Obese |
8.970400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.118300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.919100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.819500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.01660000000481E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.802800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.262800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.826150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.252200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.018000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.502160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.240600E-03 |
| Normal-VS-Type2 PRCC |
1.010900E-04 |
| Normal-VS-KIRP CIMP |
2.802300E-02 |
| Normal-VS-Unclassified PRCC |
1.455030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.175530E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.707600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.633380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.957600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.350250E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.354800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88146999999805E-05 |
| Normal-vs-N1 |
5.744100E-02 |
| Normal-vs-N2 |
2.980300E-02 |
| N0-vs-N1 |
3.787800E-02 |
| N0-vs-N2 |
4.548200E-01 |
| N1-vs-N2 |
1.092410E-01 |
|
|
